We’re pleased to announce that Victor Chen, former Sr. Managing Director, Kaiser Permanente Northern California, has joined us as a strategic advisor. Victor is a seasoned clinical research leader whose deep industry expertise will be instrumental in supporting our provider and research site clients. His expertise will be a major catalyst as we work to accelerate high-impact research and bring cutting-edge treatments to patients sooner. If you’re attending WCG MAGI in a couple of weeks, hear Victor share his insights on the future of clinical operations. We’re proud to have him representing our mission on the big stage.
At the Northeast Business Group on Health event last week, Carolyn Bradner Jasik, MD, our Associate Chief Clinical Officer, discussed how employers can help their team members tackle the growing challenge of cardiometabolic disease with precision health approaches. Key insights: ➡️ Who you partner with on AI in healthcare matters: Privacy, infrastructure, and trust aren’t optional. The future of care will be AI-enabled, but only if it’s built responsibly. ➡️ Focus on value: AI should lower the cost of care and deliver savings from efficiency, not just promises of outcomes. ➡️ Look beyond point solutions: Verily Health is building the infrastructure for connected, interoperable care. Medication is only part of the solution; support and adherence are what drive outcomes. We believe AI can meet patients where they are to help with behavior change.
As Women’s History Month comes to a close, we highlight how women are disproportionately affected by health disparities — from delayed diagnoses to gaps in maternal care, chronic disease management, and mental health support. Precision health tools can offer concrete ways to help close those gaps by: • Identifying care gaps and expanding access for women in rural areas • Surfacing sex‑specific risk patterns and personalizing care by evaluating a more complete picture of a person’s health (clinical records, wearables, lifestyle, and social drivers) With better data and intentional design, we can develop better standards, recalibrated models, and care pathways that deliver more accurate, equitable outcomes for women.
The Public Health Response and Emergency Detection through Integrated Wastewater Community Testing (PREDICT) Act aims to strengthen and expand the nation’s wastewater monitoring network. This network serves as a crucial early warning system, helping public health officials quickly identify and respond to disease outbreaks. Our Chief Medical and Scientific Officer, Dr. Andrew Trister, notes the PREDICT Act, a bipartisan-supported legislation, is key to bolstering the tools every community needs to identify infectious disease threats and prevent illness. Learn more about the bill and its impact on early detection.
Our CEO Stephen Gillett joined NYSE Live! He shared how our recent funding is accelerating Verily Health’s next chapter as an independent company, with a focus on scaling our precision health AI strategy. Watch to learn how the investment will be deployed to achieve our mission of bringing the promise of precision health to everyone, every day.
Prediabetes and diabetes can cause ongoing damage (such as vision loss) before people notice symptoms. Screening can save lives and improve outcomes. For support after screening, Verily Lightpath makes it easy for employers and health plans to offer data-driven, AI-enabled, personalized care to team members with chronic conditions including diabetes.
Our recent $300M funding, led by Series X Capital and including Alphabet Inc., is a powerful validation of our vision and a direct accelerator for the Verily Pre platform. As our CEO Stephen Gillett discusses in his recent blog, we will be focusing on: • Expanding Verily Pre capabilities with the latest technology • Launching new agents for both the Pre Data & AI Exchange and our consumer-facing Verily Me app • Driving new commercial opportunities globally • Expanding tools for clinical researchers and drug development Pre unifies complex health data into actionable intelligence, empowering the next generation of AI-enabled care that is more predictable, preventative, and precise.
Digital health is undergoing a radical shift. Conversations are moving from "What’s wrong?" to "Here is what we’ve found and what you should do next." This was the focus of our SXSW session: "How AI is Enabling A Radical Shift in Understanding Your Health." With an engaged audience, Dr. Vindell Washington, John Gerzema and Arundhati Parmar discussed three critical insights that are driving the future of digital health: 1️⃣ The key to valuable health AI is context, not a blank cursor. We are moving beyond "fill in the blank" interactions by building suggestions into the experience and providing the "prompts" users need to script their own health journey. 2️⃣ By putting data into context, we can identify gaps in care and start personalized conversations based on a user's medical history. This process turns raw health records into a personalized roadmap for care. 3️⃣ The dialogue in digital health is changing, building a bridge between raw health data and actionable expectations. "Health AI will evolve like any other great wellness tool. Users will arrive with a specific set of needs and jobs to be done, and we intend to be ready to support them," said Dr. Washington. Thank you to everyone who joined us in Austin! Let's continue building the future of health, together.
Big news! We've secured a $300M funding round led by Series X Capital, with additional backing from Alphabet Inc., UCHealth, and the University of Colorado Anschutz. This milestone will advance the next phase of our precision health strategy. To mark this new chapter, we are officially moving forward as “Verily Health”, with a focus on accelerating our AI roadmap, including our health data platform, Verily Pre. Pre unifies siloed, complex and unstructured health data, enabling organizations across the healthcare ecosystem to transform their data into actionable intelligence. This transformation can speed vital drug development and deliver the next generation of care that is more personal, predictive, and precise, improving quality of life, reducing clinician burden and closing care gaps. We thank our investors for their partnership and support in bringing clinically-informed, AI-driven solutions to advance personalized care.
We're excited to continue expanding our collaboration with NVIDIA to enhance precision health! Verily is testing the open source Nemotron model family to power the next generation of our digital health AI tools. In healthcare, open models matter; they give organizations like ours the ability to fine-tune for clinical precision, maintain full transparency, and keep patient data secure within our own infrastructure. We're starting with our AI companion, Violet, available via the Verily Me app where open architecture can deliver lower latency and greater accuracy for the people who depend on it!
